ClinicalTrials.Veeva

Menu
I

Integrated Clinical Research | Sherman Oaks, CA

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Boric Acid
Muvalaplin

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 5 total trials

Assessing the Impact of Muvalaplin on Major Cardiovascular Events in Adults With Elevated Lipoprotein(a) (MOVE-Lp(a))

The purpose of this study is to evaluate the efficacy of muvalaplin in reducing cardiovascular risk in participants with high lipoprotein(a) who have...

Enrolling
Atherosclerotic Cardiovascular Disease (ASCVD)
Elevated Lp(a)
Drug: Placebo
Drug: Muvalaplin

To evaluate whether individuals drawn from the intended use population can successfully interpret and follow the IFU for the Mia by XytoTest self-col...

Enrolling
HPV - Anogenital Human Papilloma Virus Infection
HPV
Diagnostic Test: Rovers Cervex-Brush
Diagnostic Test: Mia by XytoTest

This is a Phase 3 clinical study to evaluate the efficacy, safety, and tolerability of boric acid 600 mg vaginal inserts in patients with VVC.

Active, not recruiting
Vulvovaginal Candidiasis (VVC)
Vulvovaginal Candidiasis, Genital
Other: Placebo
Drug: Boric acid

This study is a Phase 3, randomized, modified double-blind study which aims to document the safety profile of the PCV21 vaccine (investigational pneu...

Active, not recruiting
Pneumococcal Immunization
Biological: Varivax
Biological: M-M-R II vaccine

Trial sponsors

Lilly logo
Sanofi logo
Sanofi logo
M
P

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems